Welcome to our dedicated page for FIGS SEC filings (Ticker: FIGS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
FIGS, Inc. filings document the company’s healthcare apparel business, operating results and public-company governance. Form 8-K reports furnish earnings releases and Regulation FD presentations covering net revenues, scrubwear and non-scrubwear categories, U.S. and international sales, active customer measures, average order value, gross margin, operating expenses and outlook disclosures.
The company’s proxy materials address board matters, executive compensation, equity awards and annual meeting governance. Other current reports disclose material agreements, including office lease arrangements related to corporate facilities. Together, FIGS’ regulatory filings describe the business economics, capital and compensation structures, governance practices and material events of a direct-to-consumer healthcare apparel issuer.
Jao Hsiao Yueh reported acquisition or exercise transactions in this Form 4 filing.
FIGS, Inc. director Jao Hsiao Yueh received a grant of 15,456 restricted stock units (RSUs) of Class A Common Stock as annual director compensation. The RSUs vest in full on the earlier of the one-year anniversary of June 3, 2026 or the next annual stockholder meeting, subject to continued service. Following this grant, the director holds 97,719 shares directly.
WHELAN MELANIE ANYA reported acquisition or exercise transactions in this Form 4 filing.
FIGS, Inc. director Melanie Anya Whelan received an equity award of 15,456 restricted stock units (RSUs), each representing one share of Class A common stock. The award is her automatic annual grant under the company’s Non-Employee Director Compensation Program.
The RSUs vest in full on the earlier of the one-year anniversary of June 3, 2026, or the next FIGS annual stockholder meeting after that date, as long as she continues serving as a director. Following this grant, Whelan directly holds 55,683 shares of FIGS Class A common stock.
Marte Mario Jesus reported acquisition or exercise transactions in this Form 4 filing.
FIGS, Inc. director Mario Jesus Marte reported an equity compensation grant of 15,456 restricted stock units (RSUs), each representing one share of Class A Common Stock. These RSUs are his automatic annual grant under the Non-Employee Director Compensation Program.
The RSUs vest in full on the earlier of the one-year anniversary of June 3, 2026 or the next annual stockholder meeting after that date, contingent on continued board service. Following this grant, Marte holds a total of 86,046 Class A Common Stock shares and RSUs directly.
Lin Kenneth Jian-Hong reported acquisition or exercise transactions in this Form 4 filing.
FIGS, Inc. director Kenneth Jian-Hong Lin reported an equity compensation grant in the form of restricted stock units (RSUs). He was awarded 15,456 RSUs of Class A Common Stock at a grant price of $0.00 per unit as part of the company’s Non-Employee Director Compensation Program.
These RSUs were granted automatically on the date of FIGS’ 2026 annual stockholder meeting and will vest in full on the earlier of the one-year anniversary of June 3, 2026 or the next annual meeting after that date, subject to his continued service. Following this award, Lin is reported as beneficially owning 161,705 shares and RSUs of Class A Common Stock.
Willhite John Martin reported acquisition or exercise transactions in this Form 4 filing.
FIGS, Inc. director John Martin Willhite received an equity grant of 15,456 restricted stock units (RSUs) of Class A Common Stock. The grant represents his annual equity award under the company’s Non-Employee Director Compensation Program, automatically granted on the date of the 2026 annual meeting of stockholders.
The RSUs vest in full on the earlier of the one-year anniversary of June 3, 2026 or the next annual meeting of stockholders following that date, subject to his continued service. Following this award, he directly holds 3,263,095 shares of FIGS Class A Common Stock.
Antrum Sheila reported acquisition or exercise transactions in this Form 4 filing.
FIGS, Inc. director Sheila Antrum received a grant of 15,456 restricted stock units as part of the company’s non-employee director compensation program. The RSUs vest in full on the earlier of the one-year anniversary of June 3, 2026 or the next annual shareholder meeting. Following this award, she holds 115,663 shares and RSUs directly.
FIGS, Inc. director Melanie Anya Whelan received a grant of 22,863 stock options as compensation for consulting services beyond her board role. The options have an exercise price of $11.51 per share and expire on May 12, 2036.
The option grant vests in full and becomes exercisable on May 12, 2027, contingent on her continued service through that date. In addition, she holds 10,815 shares of Class A Common Stock, 29,412 unvested restricted stock units, and 52,037 shares underlying vested options.
Catherine Eva Spear filed an amended Schedule 13D reporting her beneficial ownership in FIGS, Inc. Class A common stock. She reports beneficial ownership of 27,668,112 shares, representing 15.0% of the Class A common stock, based on 158,763,612 shares outstanding as of April 30, 2026.
Her position includes directly held Class A and Class B shares, convertible Class B shares, vested options, restricted stock units, and shares held through trusts and an LLC. The filing also notes an April 2, 2026 open market sale of 62,335 Class A shares at $14.44 per share to cover taxes and fees on vested restricted stock units.
Heather Hasson filed an amended Schedule 13D for FIGS, Inc., reporting beneficial ownership of 14,421,434 shares of Class A Common Stock, representing 8.4% of the class based on 158,763,612 shares outstanding as of April 30, 2026. Her holdings include directly owned Class A shares, Class B shares convertible into Class A on a one-to-one basis, restricted stock units and vested options exercisable within 60 days, as well as shares held through various trusts and Hollywood Capital Partners LLC. The filing notes a recent sale of 32,385 shares in open market transactions at a weighted average price of $14.3339 per share, executed solely to cover required taxes and fees upon vesting and settlement of restricted stock units. She disclaims beneficial ownership of shares held by other parties to a Voting Agreement.
FIGS, Inc. delivered strong top-line growth in the quarter ended March 31, 2026, with net revenues rising 28.0% to $159.9 million from $124.9 million a year earlier, driven by more orders from both new and existing customers and a higher average order value.
Gross margin held at a high 67.7%, up slightly from 67.6%, as price increases and efficiency gains largely offset higher tariffs and product mix shifts. Net income improved to $6.3 million from a small loss, giving a 3.9% net margin, while adjusted EBITDA increased to $13.9 million and an 8.7% margin.
Active customers grew 12.2% year over year to about 3.0 million, and average order value climbed to $124 from $119. Despite the profit improvement, operating cash flow swung to an outflow of $3.2 million, mainly due to working capital and tax-related equity settlements, resulting in free cash flow of negative $5.6 million.
The company ended the quarter with $74.3 million in cash and cash equivalents and $202.7 million in short-term investments, and no borrowings under its $100 million credit facility. FIGS also repurchased 571,592 Class A shares for about $8.8 million, with $43.2 million remaining under its authorization, while noting ongoing gross-margin pressure and uncertainty from U.S. tariff policy.